TROBICIN Drug Patent Profile
✉ Email this page to a colleague
When do Trobicin patents expire, and when can generic versions of Trobicin launch?
Trobicin is a drug marketed by Pfizer and is included in one NDA.
The generic ingredient in TROBICIN is spectinomycin hydrochloride. There are four drug master file entries for this compound. Additional details are available on the spectinomycin hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TROBICIN?
- What are the global sales for TROBICIN?
- What is Average Wholesale Price for TROBICIN?
Summary for TROBICIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 41 |
| Patent Applications: | 4,393 |
| DailyMed Link: | TROBICIN at DailyMed |
US Patents and Regulatory Information for TROBICIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | TROBICIN | spectinomycin hydrochloride | INJECTABLE;INJECTION | 050347-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pfizer | TROBICIN | spectinomycin hydrochloride | INJECTABLE;INJECTION | 050347-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
